Alterations of global histone H4K20 methylation during prostate carcinogenesis

BMC Urology

Volumn 12, Issue , 2012, Pages

  Behbahani, Turang E ^a   Kahl, Philip ^b   Von Der Gathen, Johannes ^a   Heukamp, Lukas C ^b   Baumann, Claudia ^a   Gütgemann, Ines ^a   Walter, Bernhard ^c   Hofstädter, Ferdinand ^d   Bastian, Patrick J ^e   Von Ruecker, Alexander ^a   Müller, Stefan C ^a   Rogenhofer, Sebastian ^a   Ellinger, Jörg ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^d UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Epigenetics; H4K20; Histone; Methylation; Prostate cancer

Indexed keywords

HISTONE; HISTONE 4 LYSINE 20; UNCLASSIFIED DRUG;

ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CARCINOGENESIS; CASTRATION RESISTANT PROSTATE CANCER; CONTROLLED STUDY; GLEASON SCORE; HISTONE METHYLATION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; PROSTATECTOMY; TISSUE MICROARRAY; CELL TRANSFORMATION; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETICS; MUTATION; PROSTATE TUMOR;

CELL TRANSFORMATION, NEOPLASTIC; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; MALE; MUTATION; PROSTATIC NEOPLASMS;

EID: 84857958848     PISSN: None     EISSN: 14712490     Source Type: Journal    
DOI: 10.1186/1471-2490-12-5     Document Type: Article

References (22)

1. Histone modifications and chromatin organization in prostate cancer. Chen Z, Wang L, Wang Q, Li W, Epigenomics 2010 2 551 560 10.2217/epi.10.31 21318127
2. Epigenetic changes in prostate cancer: implication for diagnosis and treatment. Li LC, Carroll PR, Dahiya R, J Natl Cancer Inst 2005 97 105 113
3. Chromatin modifications and their function. Kouzarides T, Cell 2007 128 693 705 10.1016/j.cell.2007.02.005 17320507 (Pubitemid 46273577)
4. A chromatin-wide transition to H4K20 mono-methylation impairs genome integrity and programmed DNA rearrangements in the mouse. Schotta G, Sengupta R, Kubicek S, Malin S, Kauer M, Callén E, Celeste A, Pagani M, Opravil S, De La Rosa-Velazquez IA, Espejo A, Bedford MT, Nussenzweig A, Busslinger M, Jenuwein T, Genes Dev 2008 22 2048 2061 10.1101/gad.476008 18676810
5. Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair. Botuyan MV, Lee J, Ward IM, Kim JE, Thompson JR, Chen J, Mer G, Cell 2006 127 1361 1373 10.1016/j.cell.2006.10. 043 17190600 (Pubitemid 44960409)
6. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G, Bonaldi T, Haydon C, Ropero S, Petrie K, Iyer NG, Perez-Rosado A, Calvo E, Lopez JA, Cano A, Calasanz MJ, Colomer D, Piris MA, Ahn N, Imhof A, Caldas C, Jenuwein T, Esteller M, Nat Genet 2005 37 391 400 10.1038/ng1531 15765097
7. Histone H3 lysine 9 and H4 lysine 20 trimethylation and the expression of Suv4-20h2 and Suv-39h1 histone methyltransferases in hepatocarcinogenesis induced by methyl deficiency in rats. Pogribny IP, Ross SA, Tryndyak VP, Pogribna M, Poirier LA, Karpinets TV, Carcinogenesis 2006 27 1180 1186 10.1093/carcin/bgi364 16497704 (Pubitemid 43985433)
8. Loss of DNA methylation and histone H4 lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression of DNA methyltransferase 1, Suv4-20h2 histone methyltransferase and methyl-binding proteins. Tryndyak VP, Kovalchuk O, Pogribny IP, Cancer Biol Ther 2006 5 65 70 10.4161/cbt.5.1.2288 16322686 (Pubitemid 43234980)
9. Global histone H4K20 trimethylation predicts cancer-specific survival in patients with muscle invasive bladder cancer. Schneider AC, Heukamp LC, Rogenhofer S, Fechner G, Bastian PJ, von Ruecker A, Müller SC, Ellinger J, BJU Int
10. Global levels of histone modifications predict prognosis in different cancers. Seligson DB, Horvath S, McBrian MA, Yu H, Tze S, Grunstein M, Kurdistani SK, Am J Pathol 2009 174 1619 1628 10.2353/ajpath.2009.080874 19349354
11. Prognostic relevance of global histone H3 lysine 4 (H3K4) methylation in renal cell carcinoma. Ellinger J, Kahl P, Mertens C, Rogenhofer S, Hauser S, Hartmann W, Bastian PJ, Buettner R, Mueller SC, von Ruecker SC, Int J Cancer 2010 127 2360 2366 10.1002/ijc.25250 20162570
12. Global levels of histone modifications predict prostate cancer recurrence. Ellinger J, Kahl P, von der Gathen J, Rogenhofer S, Heukamp LC, Gutgemann I, Walter B, Hofstädter F, Buttner R, Mueller SC, Bastian PJ, von Ruecker A, Prostate 2010 70 61 69 10.1002/pros.21038 19739128
13. Global histone modification patterns predict risk of prostate cancer recurrence. Seligson DB, Horvath S, Shi T, Yu H, Tze S, Grunstein M, Kurdistani SK, Nature 2005 435 1262 1266 10.1038/nature03672 15988529 (Pubitemid 40943093)
14. Loss of Histone H4K20 Trimethylation Occurs in Preneoplasia and Influences Prognosis of Non-Small Cell Lung Cancer. Van den Broeck A, Bramilla E, Moro-Sibilot D, Lantuejoul S, Brambilla C, Eymin B, Khochbin S, Gazzeri S, Clin Cancer Res 2008 14 7237 7245 10.1158/1078-0432.CCR-08-0869 18974389
15. Comparative Analyses of SUV420H1 Isoforms and SUV420H2 Reveal Differences in Their Cellular Localization and Effects on Myogenic Differentiation. Tsang LK, Hu N, Underhill DA, PLoS One 2010 5 14447 10.1371/journal.pone.0014447 21206904
16. Application of histone modification in the risk prediction of the biochemical recurrence after radical prostatectomy. Zhou LX, Li T, Huang YR, Sha JJ, Sun P, Li D, Asian Journal of Andrology 2010 12 171 179 10.1038/aja.2009.81 19935671
17. Global Histone H3K27 Methylation Levels are Different in Localized and Metastatic Prostate Cancer. Ellinger J, Kahl P, von der Gathen J, Heukamp LC, Gütgemann I, Walter B, Hofstädter F, Bastian PJ, von Ruecker A, Müller SC, Rogenhofer S, Cancer Invest
18. Screening, risk assessment, and the approach to therapy in patients with prostate cancer. Freedland SJ, Cancer 2011 117 1123 1135 10.1002/cncr.25477 20960523
19. SUV420H2 mediated H4K20 trimethylation enforces RNA polymerase II promoter-proximal pausing by blocking hMOF dependent H4K16 acetylation. Kapoor-Vazirani P, Kagey JD, Vertino PM, Mol and Cell Biology 2011 8 1594 1609
20. Methylation mediated silencing of TMS1/ASC gene in prostate cancer. Das PM, Ramachandran K, Vanwert J, Ferdinand L, Gopisetty G, Reis IM, Singal R, Mol Cancer 2006 18 28
21. Methylation of apoptosis related genes in the pathogenesis and prognosis of Prostate cancer. Suzuki M, Shigematsu H, Shivapurkar N, Reddy J, Miyajima K, Takahashi K, Gazdar AF, Frenkel EP, Cancer Let 2006 242 222 230 10.1016/j.canlet.2005.11.002 (Pubitemid 44485305)
22. Decoding the histone H4 lysine 20 methylation mark. Balakrishnan L, Milavetz B, Crit Rev Biochem Mol Bio 2010 45 440 452 10.3109/10409238.2010. 504700